Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism
Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism
复制标题
DOI:
10.1016/j.neurobiolaging.2012.07.001
复制
发表时间:
2012-12-01
影响因子:
4.2
通讯作者:
Rogaeva, Ekaterina
中科院分区:
文献类型:
--
作者:
Hazrati, Lili-Naz;Van Cauwenberghe, Caroline;Rogaeva, Ekaterina
CR1 is a novel Alzheimer's disease (AD) gene identified by genome-wide association studies (GWAS). Recently, we showed that AD risk could be explained by an 18-kilobase insertion responsible for the complement component (3b/4b) receptor 1 (CR1)-S isoform. We investigated the relevance of the CR1 isoforms to AD in a Canadian dataset. Also, we genotyped rs4844610 tagging the GWAS-significant CR1 single nucleotide polymorphisms. Individuals with F/S genotype had a 1.8 times increased risk for AD compared with F/F genotype (p-adjusted = 0.003), while rs4844610 was only marginally significant (p-adjusted = 0.024). The analyses of brain samples demonstrated that the CR1-S isoform is expressed at lower protein levels than CR1-F (p < 0.0001) hence likely associated with increased complement activation. Intriguingly, our neuropathological results show that the pattern of CR1 expression in neurons is different between the F/F and F/S genotypes (filiform vs. vesicular-like profiles). Furthermore, double labeling studies supported a differential distribution of CR1 in neurons (endoplasmic reticulum intermediate compartment vs. lysosomes). These observations indicate that the CR1-S and CR1-F isoforms could be processed in different ways in neurons. In conclusion, our results support that the CR1-S isoform explains the GWAS signals and open a novel prospect for the investigation of CR1-related disease mechanisms. (C) 2012 Elsevier Inc. All rights reserved.